Mani Mohindru is CFO & CSO at Cara Therapeutics, Inc. (CARA). They have made 9 open-market trades across 2 companies since 2018, most recently 2026-07-14.
CIK 0001664708
2 open-market purchases totalling $80K since 2026, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 22,196 | $118K |
| CRDF | 34,364 | $32K |
| Total | $150K |
Shares reported on the most recent Form 4, priced at the 2026-07-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRDF | BUY | 2026-07-14 | 2026-07-16 | $1.46 | $50K | -8.9% | +1.6% | +8.8% |
| CRDF | BUY | 2026-06-18 | 2026-06-22 | $1.21 | $30K | -2.7% | -34.4% | +5.0% |
| CARA | SELL | 2019-12-04 | 2019-12-04 | $17.05 | $162K | +1.2% | -10.5% | -11.8% |
| CARA | SELL | 2019-07-15 | 2019-07-17 | $25.00 | $936K | -14.6% | -12.8% | -27.7% |
| CARA | SELL | 2019-05-29 | 2019-05-30 | $21.39 | $107K | -5.4% | +6.8% | +9.8% |
| CARA | SELL | 2019-03-13 | 2019-03-15 | $19.12 | $613K | +2.3% | +5.8% | +8.7% |
| CARA | SELL | 2018-12-28 | 2019-01-02 | $12.55 | $56K | +3.8% | +3.7% | +34.6% |
| CARA | SELL | 2018-11-15 | 2018-11-16 | $18.50 | $297K | -2.9% | -26.4% | -12.9% |
| CARA | SELL | 2018-10-17 | 2018-10-19 | $20.19 | $648K | -6.8% | -10.6% | -23.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.